Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

How do US orthopaedic surgeons view placebo-controlled surgical trials? A pilot online survey study

Bernstein MH. et al, (2022), Journal of Medical Ethics

How do US orthopaedic surgeons view placebo-controlled surgical trials? A pilot online survey study

Bernstein MH. et al, (2022), Journal of Medical Ethics

How do US orthopaedic surgeons view placebo- controlled surgical trials? A pilot online survey study

WARTOLOWSKA K., (2022), Journal of Medical Ethics

Consistencies and Differences in Intermediate Physiological Phenotypes of Vascular Ageing between Ischaemic Stroke Aetiologies

Webb AJS. et al, (2022), Cerebrovascular Diseases, 1 - 8

Low Heart Rate Is Associated with Cerebral Pulsatility after TIA or Minor Stroke.

Webb AJS. et al, (2022), Ann Neurol

Patient-reported outcome measures (PROMs) as proof of treatment efficacy

Kluzek S. et al, (2022), BMJ Evidence-Based Medicine, 27, 153 - 155

Aortic Stiffness, Pulse Pressure, and Cerebral Pulsatility Progress Despite Best Medical Management: The OXVASC Cohort

Webb AJS. et al, (2022), Stroke, 53, 1310 - 1317

Placebo's invisible brother: a restricted scoping review of the biomedical literature on the nocebo effect

Sweeney OJ. et al, (2022), Pain, Publish Ahead of Print

Big cohort studies offer insights into preventable risk factors

Wartolowska KA. and Webb AJS., (2021), European Heart Journal, 42, 4280 - 4281

White matter damage due to pulsatile versus steady blood pressure differs by vascular territory: a cross-sectional analysis of the UK Biobank cohort study.

WARTOLOWSKA K., (2021), Journal of Cerebral Blood Flow and Metabolism

Design of a randomised, double-blind, crossover, placebo-controlled trial of effects of sildenafil on cerebrovascular function in small vessel disease: Oxford haemodynamic adaptation to reduce pulsatility trial (OxHARP)

Webb A. et al, (2021), European Stroke Journal, 6, 283 - 290

Blood Pressure Determinants of Cerebral White Matter Hyperintensities and Microstructural Injury: UK Biobank Cohort Study

Wartolowska KA. and Webb AJS., (2021), Hypertension, 78, 532 - 539

Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study

Wartolowska KA. and Webb AJS., (2021), European Heart Journal, 42, 750 - 757

Progression of Beat-to-Beat Blood Pressure Variability Despite Best Medical Management

Webb AJS. et al, (2020), Hypertension

A Higher Grey Matter Density in the Amygdala and Midbrain Is Associated with Persistent Pain Following Total Knee Arthroplasty

Lewis GN. et al, (2020), Pain Medicine

Reply to Banik.

Kjær SW. et al, (2020), Pain, 161, 1939 - 1940

Neuromodulation: more than a placebo effect?

Kjær SW. et al, (2020), Pain, 161, 491 - 495

Pain, placebo, and test of treatment efficacy: a narrative review

Vase L. and Wartolowska K., (2019), British Journal of Anaesthesia, 123, e254 - e262

Response to "Treating patients rather than their functional neuroimages" (Br J Anaesth 2018; 121: 969-71).

Wanigasekera V. et al, (2019), Br J Anaesth, 123, e166 - e171

The nocebo effect as a source of bias in the assessment of treatment effects

Wartolowska K., (2019), F1000Research, 8, 5 - 5

Load More

Include forthcoming?